|
1
|
Wong CF, Barnes LM, Dahler AL, et al: E2F
suppression and Sp1 overexpression are sufficient to induce the
differentiation-specific marker, transglutaminase type 1, in a
squamous cell carcinoma cell line. Oncogene. 24:3525–3534. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruckman KC, Schönleben F, Qiu W, Woo VL
and Su GH: Mutational analyses of the BRAF, KRAS, and PIK3CA genes
in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 110:632–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong CF, Barnes LM, Dahler AL, et al: E2F
modulates keratinocyte squamous differentiation: implications for
E2F inhibition in squamous cell carcinoma. J Biol Chem.
278:28516–28522. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong CF, Barnes LM, Smith L, Popa C,
Serewko-Auret MM and Saunders N: E2F6: a member of the E2F family
that does not modulate squamous differentiation. Biochem Biophys
Res Commun. 324:497–503. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polyak K, Kato JY, Solomon MJ, et al:
p27Kip1, a cyclin-Cdk inhibitor, links transforming
growth factor-beta and contact inhibition to cell cycle arrest. J
Gene Dev. 8:9–22. 1994.
|
|
6
|
DeGregori J, Kowalik T and Nevins JR:
Cellular targets for activation by the E2F1 transcription factor
include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol.
15:4215–4224. 1995.PubMed/NCBI
|
|
7
|
DeGregori J, Leone G, Miron A, Jakoi L and
Nevins JR: Distinct roles for E2F proteins in cell growth control
and apoptosis. Proc Natl Acad Sci USA. 94:7245–7250. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu L, Timmers C, Maiti B, et al: The
E2F1-3 transcription factors are essential for cellular
proliferation. Nature. 414:457–462. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Z, Zheng S and Yu Q: The E2F family and
the role of E2F1 in apoptosis. Int J Biochem Cell Biol.
41:2389–2397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Helin K, Jin P and Nadal-Ginard B:
Inhibition of in vitro myogenic differentiation by cellular
transcription factor E2F1. Cell Growth Differ. 6:1299–1306.
1995.PubMed/NCBI
|
|
11
|
Guy CT, Zhou W, Kaufman S and Robinson MO:
E2F-1 blocks terminal differentiation and causes proliferation in
transgenic megakaryocytes. Mol Cell Biol. 16:685–693.
1996.PubMed/NCBI
|
|
12
|
Fajas L, Landsberg RL, Huss-Garcia Y,
Sardet C, Lees JA and Auwerx J: E2Fs regulate adipocyte
differentiation. Dev Cell. 3:39–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kozubek A and Tyman JHP: Resorcinolic
lipids, the natural non-isoprenoid phenolic amphiphiles and their
biological activity. Chem Rev. 99:1–25. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mutoh M, Takahashi M, Fukuda K, et al:
Suppression of cyclooxygenase-2 promoter-dependent transcription
activity in colon cancer cells by chemopreventive agents with a
resorcin-type structure. Carcinogenesis. 21:959–963. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hasegawa R, Furukawa F, Toyoda K, et al:
Inhibitory effect of antioxidants on
N-bis(2-hydroxypropyl)nitrosamine-induced lung carcinogenesis in
rats. Jpn J Cancer Res. 81:871–877. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maruyama H, Amamura T, Nakae D, et al:
Effect of catechol and its analogs on pancreatic carcinogenesis
initiated by N-nitrosobis(2-oxopropyl)amine in Syrian
hamsters. Carcinogenesis. 12:1331–1334. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SG, Jeong JH, Park YW, et al:
4-Hexylresorcinol inhibits transglutaminase-2 activity and has
synergistic effects along with cisplatin in KB cells. Oncol Rep.
25:1597–1602. 2011.PubMed/NCBI
|
|
18
|
Kim SG, Lee SW, Park YW, Jeong JH and Choi
JY: 4-hexylresorcinol inhibits NF-κB phosphorylation and has a
synergistic effect with cisplatin in KB cells. Oncol Rep.
26:1527–1532. 2011.PubMed/NCBI
|
|
19
|
Kim JY, Choi JY, Jeong JH, et al: Low
molecular weight silk fibroin increases alkaline phosphatase and
type I collagen expression in MG63 cells. BMB Rep. 43:52–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trollinger DR, Cascio WE and Lemasters JJ:
Selective loading of Rhod 2 into mitochondria shows mitochondrial
Ca2+ transients during the contractile cycle in adult
rabbit cardiac myocytes. Biochem Biophy Res Commun. 236:738–742.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wagenblast J, Baghi M, Arnoldner C, et al:
Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.
Anticancer Res. 28:2239–2243. 2008.PubMed/NCBI
|
|
22
|
Braig M, Lee S, Loddenkemper C, et al:
Oncogene-induced senescence as an initial barrier in lymphoma
development. Nature. 436:660–665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Z, Trotman LC, Shaffer D, et al:
Crucial role of p53-dependent cellular senescence in suppression of
Pten-deficient tumorigenesis. Nature. 436:725–730. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Michaloglou C, Vredeveld LC, Soengas MS,
et al: BRAFE600-associated senescence-like cell cycle arrest of
human naevi. Nature. 436:720–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hazar-Rethinam M, Cameron SR, Dahler AL,
et al: Loss of E2F7 expression is an early event in squamous
differentiation and causes derepression of the key differentiation
activator Sp1. J Invest Dermatol. 131:1077–1084. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muller H, Bracken AP, Vernell R, et al:
E2Fs regulate the expression of genes involved in differentiation,
development, proliferation, and apoptosis. Genes Dev. 15:267–285.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dicker AJ, Popa C, Dahler AL, et al: E2F-1
induces proliferation-specific genes and suppresses squamous
differentiation-specific genes in human epidermal keratinocytes.
Oncogene. 19:2887–2894. 2000. View Article : Google Scholar
|
